Limit alcohol because it raises pancreatitis risk and can worsen low blood sugar
This project will use an emulated trial design to see if starting GLP-1/GIP drugs actually leads to fewer heart problems, especially in communities with more health disparities
Long-acting GIPR agonist LY3537021 reduces body weight and fasting blood glucose in patients with T2D: Preclinical development and phase 1 randomized ascending dose studies
Here are a few to keep in mind: Common Side Effects : Nausea Vomiting Diarrhea Stomach discomfort Loss of appetite Serious Side Effects (less common): Pancreatitis (inflammation of the pancreas) Kidney issues (changes in urination or swelling in the legs/ankles) Thyroid problems (a lump or swelling in the neck) What to Do : If you experience severe abdominal pain, nausea, or changes in urination, contact your healthcare provider immediately
Personalized Hormone Optimization Using Genetic Testing The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), GIPR (rs1800437), and MC4R (rs17782313) variants that relate to GLP-1 and related signaling pathways
Living with the unpredictable, invisible, and often entirely overwhelming symptoms of Long COVID, ME/CFS, and dysautonomia is an exhausting daily reality
